Evome Medical CFO resigns; reduces acquisition debt by $535K, appoints interim CFO

EVOME MEDICAL TECHNOLOGIES INC.

CFO Natalia Vakhitova resigned Jan 22, 2024; no disagreement stated. Cherine Pottinger-Harris appointed interim CFO effective Jan 30.
Sold Arrowhead Medical, reducing acquisition bank debt by $535,093; intercompany debt reduced $209,171.
Promoted Carmine Tronolone to GM of Biodex Production; Bill Hauer appointed VP Marketing & Sales.
Preparing to launch SpaceTek Knee (co-developed with NASA) and Reactive Step Trainer in 2024.
Granted 460,000 stock options to three executives, vesting over 3 years.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Cherine Pottinger-Harris

Principal Accounting Officer and interim Chief Financial Officer

EVOME MEDICAL TECHNOLOGIES INC.

Effective: 2024-01-30
Filed: February 2, 2024, 6:59 PM ET

On January 30, 2024, the Board appointed Cherine Pottinger-Harris as the Company's Principal Accounting Officer and interim Chief Financial Officer.

Departed (interim)

Natalia Vakhitova

Principal Accounting Officer and Chief Financial Officer

EVOME MEDICAL TECHNOLOGIES INC.

Effective: 2024-01-22
Successor: Cherine Pottinger-Harris
Filed: February 2, 2024, 6:59 PM ET

On January 22, 2024, Natalia Vakhitova notified the Board of Directors of Evome Medical Technologies Inc. (the "Company") of her intention to resign as the Company's Principal Accounting Officer and Chief Financial Officer effective on January 22, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Cherine Pottinger-Harris was appointed as Principal Accounting Officer and interim Chief Financial Officer at EVOME MEDICAL TECHNOLOGIES INC..

Action: appointed
Role: Principal Accounting Officer and interim Chief Financial Officer

Exact text from the filing

On January 30, 2024, the Board appointed Cherine Pottinger-Harris as the Company's Principal Accounting Officer and interim Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Natalia Vakhitova resigned as Principal Accounting Officer and Chief Financial Officer at EVOME MEDICAL TECHNOLOGIES INC..

Action: resigned
Role: Principal Accounting Officer and Chief Financial Officer

Exact text from the filing

On January 22, 2024, Natalia Vakhitova notified the Board of Directors of Evome Medical Technologies Inc. (the "Company") of her intention to resign as the Company's Principal Accounting Officer and Chief Financial Officer effective on January 22, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001062993-24-001870

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.